Paul F. Alewood

发表

Drugs from deadly doses

Kenneth D. Winkel, Bryan G. Fry, Paul F. Alewood, 1998 .

Conotoxins and their potential pharmaceutical applications

David J. Craik, Paul F. Alewood, D. Craik, 1999 .

Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a

Glenn F. King, Paul F. Alewood, Sulayman D. Dib-Hajj, 2017, Scientific Reports.

In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences.

Stephen B. H. Kent, Paul F. Alewood, Alun Jones, 2009 .

Inhibition of Protein Interactions with the β2 Sliding Clamp of Escherichia coli DNA Polymerase III by Peptides from β2-Binding Proteins

Gene Wijffels, Nicholas E. Dixon, Paul F. Alewood, 2004 .

Solution structure and proposed binding mechanism of a novel potassium channel toxin κ-conotoxin PVIIA

David J. Craik, Martin J. Scanlon, David Naranjo, 1997 .

Venomics: a new paradigm for natural products-based drug discovery

Mehdi Mobli, Glenn F. King, Paul F. Alewood, 2010, Amino Acids.

In situ Neutralization in Boc‐Chemistry ‐ Solid Phase Peptide Synthesis.

Stephen B. H. Kent, Paul F. Alewood, Alun Jones, 1993 .

A one‐variable topographical descriptor for the β‐turns of peptides and proteins

Pr Andrews, Paul F. Alewood, Jonathan B. Ball, 1990 .

Conformational constraints: Nonpeptide β‐turn mimics

Paul F. Alewood, P. Alewood, J. B. Ball, 1990 .

Cellular and Molecular Life Sciences the Insecticidal Potential of Venom Peptides

Glenn F. King, Paul F. Alewood, Volker Herzig, 2022 .

Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain

Paul F. Alewood, Irina Vetter, Katharina Zimmermann, 2016, Toxins.